Albemarle Corporation to Attend UBS Boston Chemicals Conference

 Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today Scott Tozier, Executive Vice President and Chief Financial Officer, David Ryan, Vice President, Corporate Strategy and Investor Relations, and Sharon McGee, Vice President, Corporate Development and Investor Relations, will attend UBS Boston Chemicals Conference in Boston on Tuesday, May 21. Tozier, Ryan and McGee will be available for one-on-one meetings.   

About Albemarle
Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics.  Working side-by-side with our customers, we develop value-added, customized solutions that make them more competitive. Our solutions combine the finest technology and ingredients with the knowledge and know-how of our highly experienced and talented team of operators, scientists and engineers.

Discovering and implementing new and better performance-based sustainable solutions is what motivates all of us. We think beyond business-as-usual to drive innovations that create lasting value. Albemarle employs approximately 5,400 people and serves customers in approximately 100 countries. We regularly post information to, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding our company, its businesses and the markets it serves.

View original content to download multimedia:

SOURCE Albemarle Corporation

Media Contact: Hailey Quinn, (980) 299-5640, [email protected] ; Investor Relations Contact: David Ryan, (980) 299-5641, [email protected]